Benzinga | Feb 8, 2021 07:35AM EST

Bio-Techne And RenalytixAI Joint Venture Kantaro Biosciences Enters Marketing And Distribution Agreement With Atrys Health; Atrys To Offer Kantaro's SARS-CoV-2 IgG Antibody Test Kits In Select European And South American Countries

NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (NASDAQ:RNLX), and manufacturing partner Bio-Techne Corporation (NASDAQ:TECH), entered into a marketing and distribution agreement with Atrys Health (BME: ATRY), a biomedical company dedicated to providing diagnostic services and medical treatments of excellence. Atrys Health will offer COVID-SeroKlir and COVID-SeroIndex, Kantaro's quantitative SARS-CoV-2 IgG antibody test kits, in select European and South American territories, including Spain, Portugal, Colombia, Brazil, Peru and Chile.